Page last updated: 2024-10-21

phenytoin and Andersen Cardiodysrhythmic Periodic Paralysis

phenytoin has been researched along with Andersen Cardiodysrhythmic Periodic Paralysis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Phenytoin was considered for control of symptomatic VA in three patients."1.51Short-term response to phenytoin sodium in Andersen-Tawil syndrome-1 with a cardiac-dominant phenotype. ( Augustine, AJ; Bhavani, GS; Girisha, KM; Kamath, P; Kedambadi, RC; Pai, R; Pasha, SW; Prabhu, MA; Rai, MK, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rai, MK1
Pai, R1
Prabhu, MA1
Pasha, SW1
Kedambadi, RC1
Kamath, P1
Augustine, AJ1
Bhavani, GS1
Girisha, KM1

Other Studies

1 other study available for phenytoin and Andersen Cardiodysrhythmic Periodic Paralysis

ArticleYear
Short-term response to phenytoin sodium in Andersen-Tawil syndrome-1 with a cardiac-dominant phenotype.
    Pacing and clinical electrophysiology : PACE, 2019, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Algorithms; Andersen Syndrome; Arrhythmias, Cardiac; Female; Humans; Male; Pedigr

2019